MeiraGTx Holdings plc Asset Retirement Obligation, Liabilities Settled
MeiraGTx Holdings plc (MGTX) reported Asset Retirement Obligation, Liabilities Settled of $1.70 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Asset Retirement Obligations
us-gaap:AssetRetirementObligationLiabilitiesSettled · last filed 2026-08-13
- MeiraGTx Holdings plc asset retirement obligation, liabilities settled for the quarter ending 2025-03-31 was $1.70M.
- MeiraGTx Holdings plc asset retirement obligation, liabilities settled for fiscal 2025 was $1.70M, a 1378.26% increase from fiscal 2024.
- MeiraGTx Holdings plc asset retirement obligation, liabilities settled for fiscal 2024 was $115.00K.
| Period end | Asset Retirement Obligation, Liabilities Settled 3 month | Asset Retirement Obligation, Liabilities Settled 12 month |
|---|---|---|
| 2025-12-31 | $1.70M 10-K · filed 2026-03-30 | |
| 2025-03-31 | $1.70M 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $115.00K 10-K · filed 2026-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |